object
review
human
veterinari
literatur
biolog
apoptosi
health
diseas
tissu
must
abl
tightli
control
cell
number
tissu
size
protect
rogu
cell
threaten
homeostasi
earli
kerr
et
al
observ
singlecelldeath
phenomenon
occur
die
cell
healthi
tissu
well
cell
associ
teratogenesi
neoplasia
tumor
regress
atrophi
involut
term
apoptosi
greek
origin
apo
ptosi
fall
chosen
describ
cellular
process
program
cell
death
apoptosi
tightli
regul
intracellular
program
cell
destin
die
activ
enzym
degrad
cell
dna
nuclear
cytoplasm
protein
program
cell
death
elimin
unwant
cell
potenti
reactiv
cell
line
either
matur
process
vital
fetal
embryon
develop
tissu
remodel
cell
popul
normal
high
rate
prolifer
intestin
epithelium
depend
upon
apoptosi
maintain
necessari
number
cell
number
activ
immun
cell
must
control
contain
inflammatori
respons
hormonedepend
apoptosi
occur
estru
caus
prostat
atrophi
castrat
kerr
et
al
observ
apoptot
cell
share
mani
morpholog
featur
distinct
necrot
cell
cell
undergo
apoptosi
exhibit
follow
cell
shrinkag
chromatin
condens
nucleosom
fragment
bubbl
plasma
membran
bleb
biochem
featur
apoptosi
includ
dna
fragment
protein
cleavag
specif
locat
increas
mitochondri
membran
permeabl
appear
phosphatidylserin
cell
membran
surfac
increas
mitochondri
permeabl
lead
releas
proapoptot
protein
subsequ
format
apoptot
bodi
result
membranebound
apoptot
bodi
consum
neighbor
cell
macrophag
apoptosi
singlecel
event
induc
inflammatori
reaction
apoptosi
must
distinguish
necrosi
also
form
cellular
death
contrast
apoptosi
necrosi
genet
program
function
affect
group
neighbor
cell
produc
inflammatori
respons
death
cell
necrosi
lead
releas
alarm
signal
molecul
stimul
patternrecognit
receptor
macrophag
dendrit
cell
natur
killer
cell
presenc
necrot
cell
tissu
frequent
interpret
immun
system
danger
therefor
act
signal
initi
immun
respons
unlik
apoptosi
necrosi
cellular
swell
loss
cell
membran
integr
organel
swell
lysosom
leakag
degrad
dna
random
lyse
cell
ingest
macrophag
whether
cell
surviv
die
apoptosi
determin
balanc
proapoptot
stress
death
signal
antiapoptot
mitogen
surviv
signal
within
around
cell
see
tabl
cell
injuri
via
oxygen
depriv
heat
stress
chemic
agent
radiat
infecti
agent
genet
derang
nutrit
imbal
immunolog
reaction
eg
anaphylaxi
type
sever
cell
stress
initi
proapoptot
pathway
dysregul
apoptosi
affect
equilibrium
cell
growth
cell
death
result
organ
dysfunct
apoptosi
health
fine
balanc
process
much
littl
apoptosi
contribut
diseas
apoptosi
infect
cell
part
host
defens
mechan
virus
bacteria
howev
develop
abil
inhibit
infect
cell
apoptot
mechan
protect
environ
inhibit
apoptosi
link
uncontrol
cell
growth
format
mani
type
cancer
human
excess
apoptosi
link
stroke
alzheim
diseas
activ
restor
apoptosi
emerg
key
strategi
treatment
cancer
diseas
aim
provid
basic
review
literatur
regard
mechan
regul
apoptosi
extracellular
liganddirect
intracellular
stressinduc
stimuli
activ
highli
regul
process
caspas
play
central
role
initi
execut
intracellular
cascad
event
result
protein
nucleic
acid
cleavag
ultim
cell
death
mani
key
apoptot
protein
identifi
howev
still
much
learn
regard
molecular
mechan
action
activ
protein
knowledg
proapoptot
antiapoptot
cell
pathway
import
understand
mechan
mani
lifealt
diseas
human
anim
realiz
potenti
novel
therapeut
apoptosi
genet
encod
occur
respons
cellular
extern
stimuli
featur
character
apoptosi
protein
cleavag
hydrolysi
breakdown
nuclear
dna
recognit
apoptot
cell
phagocyt
cell
cleavag
protein
primarili
occur
activ
famili
cystein
proteas
call
caspas
cystein
aspartatespecif
proteas
caspas
synthes
inact
form
activ
specif
initi
mechan
program
cell
death
also
result
caspaseindepend
mechan
trigger
cell
membran
receptorligand
bind
damag
cell
organel
initi
caspas
cascad
known
pathway
initi
activ
caspas
cascad
program
death
cell
rout
util
depend
initi
death
signal
cell
type
involv
balanc
proapoptot
antiapoptot
signal
one
initi
path
may
lead
anoth
crosstalk
possibl
two
pathway
death
receptor
dr
extrins
mitochondri
intrins
detail
literatur
third
bcell
lymphoma
bclxl
protein
xl
bax
protein
x
bak
protein
k
cflip
flicelik
inhibitori
protein
nfkb
nuclear
factorkb
ikb
inhibitorykb
iap
inibitor
apoptosi
protein
xiap
xlink
inhibitor
apoptosi
protein
jak
janu
kinas
stat
signal
transduc
activ
transcript
mapk
mitogenactiv
protein
kinas
pkr
protein
kinas
r
cdk
cyclindepend
kinas
intrins
pathway
involv
endoplasm
reticulum
er
least
understood
pathway
believ
patholog
relev
form
apoptosi
occur
respons
cellular
stress
extrins
dr
pathway
extrins
pathway
see
figur
begin
proapoptot
receptor
cell
surfac
activ
proapoptot
molecul
ligand
specif
receptor
cell
dr
belong
tumor
necrosi
factor
tnf
receptor
superfamili
fa
receptor
intens
studi
member
fa
present
varieti
cell
type
includ
activ
b
cell
cell
ligand
activ
proapoptot
receptor
includ
fa
ligand
fasl
tnfa
tabl
fasl
express
varieti
cell
type
includ
activ
cell
natur
killer
cell
tnfa
produc
predominantli
activ
monocytemacrophag
lymphocyt
intracellular
portion
dr
known
death
domain
dd
drligand
complex
bunch
dd
brought
close
proxim
bind
site
adaptor
protein
form
adaptor
protein
specif
receptor
eg
fasassoci
dd
fadd
tnf
receptorassoci
dd
tradd
complex
ligandreceptoradaptor
protein
call
deathinduc
signal
complex
disc
lead
recruit
assembl
initi
caspas
caspas
undergo
selfprocess
releas
activ
caspas
enzym
molecul
cytosol
activ
effector
caspas
figur
illustr
sequenc
event
trigger
extrins
pathway
extrins
death
receptor
dr
pathway
proapoptot
ligand
death
signal
fa
bind
fa
tnfr
intracellular
portion
dr
known
death
domain
dd
bunch
receptorligand
complex
group
dd
bind
site
adaptor
protein
form
ligandreceptoradaptor
protein
complex
call
deathinduc
signal
complex
disc
recruit
assembl
initi
releas
activ
caspas
enzym
molecul
cytosol
activ
effector
result
nuclear
protein
cleavag
initi
apoptosi
fasl
fa
ligand
tnfr
tumor
necrosi
factor
receptor
fadd
fasassoci
death
domain
tradd
tnfassoci
death
domain
cflip
flicelik
inhibitori
protein
disc
deathinduc
signal
complex
intrins
mitochondri
pathway
intrins
mitochondri
pathway
see
figur
initi
within
cell
respons
cellular
stress
dna
damag
radic
oxygen
speci
radiat
hormon
growthfactor
depriv
chemotherapeut
agent
cytokin
glucocorticoid
initi
pathway
eventu
result
releas
proapoptot
protein
mitochondria
activ
caspas
enzym
trigger
apoptosi
success
pathway
induc
apoptosi
depend
balanc
activ
proapoptot
antiapoptot
member
bcell
superfamili
protein
tabl
superfamili
protein
deriv
name
second
member
rang
protein
found
follicular
lymphoma
famili
member
present
outer
mitochondri
membran
dimer
control
membran
permeabl
ion
channel
fashion
creation
pore
permeabl
mitochondri
outer
membran
determin
whether
releas
proapoptogen
substanc
mitochondria
famili
protein
subdivid
group
base
structur
similar
function
criteria
group
possess
antiapoptot
activ
group
ii
iii
promot
cell
death
famili
mitochondri
intrins
pathway
activ
proapoptot
protein
bax
bak
occur
convers
bid
tbid
activ
puma
noxa
initi
protein
induc
dna
damag
activ
bax
bak
oligomer
mitochondri
membran
caus
releas
sever
mitochondri
factor
cytochrom
c
combin
form
apoptosom
also
releas
mitochondria
smac
diablo
protein
inactiv
iap
activ
abl
activ
allow
apoptosi
proceed
also
releas
mitochondria
endog
aif
stimul
apoptosi
independ
caspas
bclxl
block
activ
bax
bak
bcell
iap
inhibitor
apoptosi
protein
apoptosisactiv
smac
second
mitochondrialderiv
activ
caspas
diablo
director
inhibitor
apoptosisbind
protein
low
pi
tbid
truncat
bid
endog
endonucleas
g
aif
apoptosisinduc
factor
bax
protein
x
bak
protein
k
share
characterist
domain
homolog
crucial
function
antiapoptot
famili
protein
bclxl
contain
domain
exert
control
mitochondri
permeabl
stimul
adpatp
exchang
stabil
mitochondri
inner
transmembran
potenti
prevent
open
permeabl
transit
pore
overexpress
bclxl
known
associ
number
human
malign
tabl
protein
also
act
inhibit
action
proapoptot
protein
bax
bak
proapoptot
protein
famili
initi
apoptosi
block
antiapoptot
activ
bclxl
bind
mitochondri
bind
site
trigger
activ
proapoptot
bax
bak
third
type
proapoptot
activ
cytoplasm
protein
bid
molecul
found
cytoplasm
inact
form
cleav
activ
extrins
pathway
bid
activ
refer
tbid
caus
structur
chang
bax
make
similar
structur
antiapoptot
molecul
allow
bax
transloc
mitochondria
one
method
crosstalk
occur
intrins
extrins
pathway
famili
member
interact
member
larg
number
heterodim
combin
within
cell
possibl
cell
prodeath
protein
sensit
death
cell
excess
protect
famili
member
usual
apoptosisresist
least
current
theori
describ
exact
mechan
proapoptot
protein
lead
increas
mitochondri
permeabl
first
theori
describ
insert
protein
mitochondri
membran
directli
form
channel
second
theori
explain
proapoptot
protein
interact
mitochondri
membran
protein
possibl
voltagedepend
anion
channel
form
larg
pore
size
voltagedepend
anion
channel
small
protein
pass
model
assum
conform
chang
bind
third
theori
describ
protein
modul
mitochondri
protein
result
format
permeabl
transit
pore
loss
membran
potenti
organel
swell
loss
cytochrom
c
pore
permeabl
membran
compromis
cytochrom
c
releas
combin
cytosol
molecul
call
apoptosi
activ
cytochrom
c
combin
activ
caspas
figur
bind
substanc
form
apoptosom
activ
altern
substanc
initi
intrins
extrins
pathway
tabl
phosphoprotein
transcript
factor
regul
cell
cycl
function
cell
stress
sensor
molecul
capabl
induc
intrins
mitochondri
pathway
factor
damag
dna
ioniz
radiat
genotox
drug
free
radic
activ
activ
promot
apoptosi
primarili
abil
suppress
transcript
antiapoptot
factor
like
induc
manufactur
proapoptot
factor
like
bax
insulin
growth
factor
bind
upregul
fa
receptor
bclxl
inhibit
inactiv
loss
common
abnorm
mani
human
cancer
one
veterinari
studi
show
increas
risk
cat
diagnos
oral
squamou
cell
carcinoma
expos
secondhand
tobacco
smoke
overexpress
human
cancer
commonli
disrupt
gene
also
frequent
mutat
gene
human
oral
cancer
intrins
er
pathway
third
least
understood
pathway
refer
endoplasm
reticulum
er
pathway
involv
said
abl
function
independ
mitochondria
cellular
stress
hypoxia
glucos
starvat
disturb
calcium
homeostasi
exposur
free
radic
injur
er
result
unfold
protein
reduct
protein
synthesi
normal
cell
adaptor
protein
tnf
receptorassoci
factor
bound
render
inact
stress
er
lead
dissoci
activ
activ
cleav
cleav
mechan
independ
mitochondria
although
evid
caspas
caus
releas
cytochrom
c
mitochondria
thu
stimul
intrins
pathway
tabl
mechan
crosstalk
intrins
pathway
initi
apoptosi
ito
et
al
demonstr
er
stress
caus
activ
posit
apoptosi
regul
cabl
tyrosin
kinas
known
tumorogen
characterist
result
releas
cytochrom
c
mitochondria
addit
mitochondri
pathway
proapoptot
famili
protein
bak
implic
caus
er
deplet
calcium
induc
activ
tabl
central
execution
apoptosi
part
larg
protein
famili
known
caspas
date
caspas
identifi
specif
caspas
found
rel
larg
amount
inact
precursor
call
procaspas
within
cytoplasm
procaspas
activ
method
exposur
anoth
activ
caspas
autocatalysi
associ
activ
protein
cytochrom
c
caspas
involv
apoptosi
subdivid
initi
caspas
effector
execution
caspas
initi
caspas
activ
adaptormedi
selfcleavag
specif
interact
caspas
activ
protein
promot
format
multimer
complex
necessari
bring
caspas
precursor
togeth
activ
produc
activ
tetram
caspas
cascad
strategi
activ
use
initi
caspas
cleav
activ
effector
caspas
activ
effector
caspas
select
cleav
restrict
set
target
protein
follow
aspart
residu
case
result
inactiv
target
protein
howev
also
activ
protein
either
directli
cleav
neg
regulatori
domain
indirectli
inactiv
regulatori
subunit
effector
caspas
caus
cytoskelet
filament
aggreg
clump
ribosom
particl
rearrang
rough
er
form
seri
concentr
whorl
seen
electron
microscopi
tabl
caspas
also
respons
cleav
nuclear
lamin
requir
nuclear
shrink
bud
loss
cellular
shape
membran
bleb
caspas
activ
caspaseactiv
dnaas
cad
breakdown
nuclear
dna
second
featur
apoptosi
cad
exist
inact
form
icad
nucleu
bound
subunit
effector
activ
migrat
nucleu
cleav
inhibitori
subunit
thu
activ
cad
cad
nucleas
respons
break
dna
piec
cleav
fragment
endonucleas
fragment
compos
dna
ladder
visual
agaros
gel
electrophoresi
biochem
hallmark
apoptosi
altern
pathway
granzym
b
accessori
method
trigger
apoptosi
serin
proteas
granzym
b
lymphocyt
granular
enzym
express
activ
cytotox
lymphocyt
natur
killer
cell
granzym
b
bind
cell
surfac
receptor
insulinlik
growth
factor
ii
receptor
caus
endocytosi
proteas
remain
endocyt
vesicl
stimul
activ
cytotox
cell
activ
almost
activ
effector
caspas
occur
action
granzym
b
pathway
number
caspas
sensit
target
well
uniqu
protein
normal
cleav
caspas
cleav
directli
granzym
b
mechan
depend
mitochondri
disrupt
overexpress
antiapoptot
halt
process
granzymemedi
apoptosi
integr
immun
surveil
machineri
rid
bodi
viral
infect
malignantli
transform
cell
tabl
mitochondri
factor
increas
mitochondri
outer
membran
permeabl
result
releas
mitochondri
prodeath
substanc
addit
cytochrom
c
apoptosi
induc
factor
smac
diablo
second
mitochondrialderiv
activ
caspasesdirect
inhibitor
apoptosisbind
protein
low
pi
endonucleas
g
sever
procaspas
eg
smacdiablo
bind
cytoplasm
inhibitor
apoptosi
protein
iap
neutral
antiapoptot
activ
migrat
apoptosi
induc
factor
mitochondria
nucleu
induc
caspaseindepend
chromatin
condens
dna
fragment
endonucleas
g
also
directli
caus
break
dna
independ
caspas
tabl
figur
ceramid
ceramidesphingomyelin
pathway
proceed
without
caspas
interact
ceramid
sphingolipidsign
mediat
involv
regul
differenti
growth
suppress
cell
age
stress
respons
apoptosi
variou
stress
ultraviolet
radiat
radic
oxygen
speci
chemotherapeut
tnfa
fa
activ
initi
pathway
sphingomyelinas
activ
bind
tnf
receptor
famili
dd
fadd
tradd
cleav
sphingomyelin
member
phospholipid
bilay
ceramid
ceramid
also
gener
lysosom
er
mitochondri
membran
stimul
varieti
cytotox
agent
increas
level
ceramid
initi
apoptot
program
involv
mitochondri
membran
disrupt
tabl
ceramideinduc
apoptosi
mediat
mitochondria
ceramid
accumul
mitochondri
membran
elev
ceramid
sphingosin
result
increas
mitochondri
membran
permeabl
cyctochrom
c
releas
activ
suscept
cell
ceramideinduc
apoptosi
reliant
cell
bax
ratio
ceramid
product
dna
damag
radic
oxygen
speci
also
stimul
cellular
lysosom
releas
cathepsin
lead
releas
mitochondri
factor
activ
activ
bid
inhibitor
apoptosi
wellknown
antiapoptot
factor
member
famili
tabl
dynam
equilibrium
antiapoptot
member
proapoptot
member
famili
addit
inhibitor
includ
iap
flicelik
inhibitori
protein
cflip
nuclear
factorkb
nfkb
iap
failsaf
inhibitori
mechan
exist
intrins
pathway
proapoptot
activ
counterbalanc
famili
least
protein
known
iap
eg
survivin
xiap
iap
compromis
effector
phase
apoptosi
block
inactiv
caspas
see
tabl
found
associ
activ
tnf
receptor
block
activ
upregul
nfkb
activ
iap
also
act
downstream
mitochondri
releas
cytochrom
c
prevent
activ
use
peptid
one
end
subunit
attract
iap
famili
molecul
bind
allow
remain
dormant
even
though
initi
step
activ
taken
place
overexpress
iap
associ
drugresist
phenotyp
cancer
cell
cflip
cflip
proteindefici
caspas
homolog
inhibitor
prevent
bind
variou
dr
activ
ratio
cflip
critic
assembl
disc
format
disc
recruit
cflip
bind
target
molecul
work
builtin
safeti
system
allud
integr
balanc
proapoptot
antiapoptot
mediat
upregul
cflip
associ
divers
hematolog
cancer
cell
line
sensit
mani
cancer
cell
death
ligandmedi
apoptosi
appear
mediat
cflip
downregul
appear
inactiv
mechan
cflip
prevent
apoptosi
induc
granzym
b
chemotherapeut
drug
irradi
nfjb
nfkb
transcript
factor
antiapoptot
gene
regul
compos
heterodim
subunit
provid
gene
regulatori
function
nfkb
kept
quiescent
cytoplasm
dimer
bound
repressor
inhibitor
nfkb
ikb
famili
phosphoryl
ikb
upstream
kinas
free
nfkb
transloc
nucleu
subunit
eventu
releas
dna
bind
newli
synthes
ikb
complex
nfkb
complex
transloc
back
cytoplasm
stimul
nfkb
activ
associ
acceler
growth
resist
apoptosi
propens
form
metastas
invers
inhibit
nfkb
activ
produc
increas
apoptosi
indic
balanc
cell
viabil
versu
cell
death
maintain
degre
nfkb
activ
recognit
apoptot
cell
third
characterist
apoptosi
recognit
die
cell
phagocyt
cell
apoptot
cell
express
marker
membran
recogn
phagocyt
intern
cellular
signal
phosphatidylserin
phospholipid
compon
shift
inner
outer
layer
plasma
membran
allow
earli
recognit
remov
die
cell
without
releas
proinflammatori
mediat
occur
necrosi
control
whether
proapoptot
antiapoptot
pathway
chosen
subject
posit
neg
genet
environment
regul
proapoptot
gene
activ
lead
cell
death
deactiv
gene
block
apoptot
pathway
genet
regul
also
modifi
exogen
stimuli
cell
immedi
environ
cell
destin
start
death
pathway
receiv
surviv
signal
save
cell
apoptosi
genet
regul
mostli
proapoptot
includ
cmyc
gene
famili
tumor
suppressor
gene
dr
caspas
famili
cmyc
gene
member
janu
kinas
jak
famili
involv
cell
prolifer
apoptosi
presenc
antiapoptot
cytokin
eg
insulinlik
growth
neg
regul
apoptosi
eg
cmyc
drive
cellular
prolifer
absenc
factor
cmyc
famili
promot
apoptosi
surviv
signal
growth
factor
solubl
mediat
often
releas
neighbor
cell
hematopoiet
cell
line
differenti
cell
depend
surviv
factor
like
granulocyt
macrophag
coloni
stimul
factor
granulocyt
coloni
stimul
factor
erythropoietin
b
lymphocyt
depend
certain
interleukin
matur
properli
lead
cellular
differenti
role
environment
surviv
substanc
lead
possibl
dysregul
apoptosi
presenc
inappropri
surviv
signal
observ
tumor
sepsi
apoptosi
diseas
dysregul
apoptosi
best
describ
patholog
diseas
state
induc
inhibit
cell
death
inappropri
human
excess
apoptosi
link
stroke
alzheim
diseas
reduc
apoptosi
cancer
autoimmun
diseas
apoptosi
also
play
key
role
sepsi
review
current
literatur
companion
anim
medicin
yield
research
pertain
apoptosi
field
oncolog
orthoped
virolog
well
diseas
state
tabl
list
articl
veterinari
origin
investig
apoptosi
diseas
featur
characterist
cancer
cell
uncoupl
cell
divis
cell
death
cell
die
properli
signal
oncolog
studi
investig
enhanc
apoptosi
arrest
growth
tumor
cell
one
mechan
normal
cellular
number
maintain
control
overapoptosi
defici
lead
reduc
apoptosi
tumor
develop
cancer
harbor
mutat
genom
disrupt
normal
function
wherea
other
increas
overexpress
protein
lead
cessat
normal
cellular
death
program
apoptosi
sepsi
cellular
demis
sepsi
occur
apoptosi
well
necrosi
bone
first
propos
apoptosi
contribut
multipl
organ
dysfunct
sepsi
treatment
aim
blunt
overreact
proinflammatori
respons
bone
propos
anerg
hypoimmun
aspect
sepsi
apoptosi
becom
critic
must
also
address
apoptot
loss
b
cell
cell
dendrit
cell
sepsi
decreas
antibodi
product
macrophag
activ
antigen
present
respect
leukocyt
respons
opson
phagocytosi
infect
cell
antigen
site
inflamm
neutrophil
produc
highli
toxic
unstabl
reactiv
oxygen
speci
releas
bactericid
substanc
hallmark
sepsi
loss
normal
apoptosi
neutrophil
prolong
life
produc
neighbor
cell
damag
contribut
activ
proinflammatori
cytokin
normal
proinflammatori
mediat
tnfa
ifng
releas
macrophag
neutrophil
overlap
effect
function
limit
damag
combat
pathogen
organ
elimin
foreign
antigen
promot
repair
antiinflammatori
cytokin
tgfb
solubl
receptor
receptor
antagonist
also
quickli
releas
tri
reduc
local
contain
inflammatori
respons
mani
inflammatori
compon
key
factor
respons
dysregul
apoptosi
immun
cell
sepsi
key
cell
involv
inflammatori
process
neutrophil
macrophag
dendrit
cell
lympho
glucocorticoid
immunosuppress
effect
canin
lymphocyt
may
involv
apoptosi
cyte
also
cell
target
apoptosi
apoptosi
immun
cell
normal
patholog
process
inflammatori
cell
must
elimin
inflamm
continu
unab
howev
sepsi
overwhelm
inflammatori
process
like
trauma
sever
burn
extens
cell
death
lymphocyt
dendrit
cell
delay
cell
death
neutrophil
lead
blunt
immun
respons
coincid
increas
cellular
damag
neutrophil
one
first
cell
migrat
site
inflamm
averag
half
life
hour
unstimul
neutrophil
releas
circul
apoptot
program
activ
studi
shown
sepsi
shorten
well
prolong
life
span
activ
neutrophil
earli
delay
apoptosi
respect
earli
apoptosi
neutrophil
dampen
respiratori
burst
activ
may
lessen
secondari
tissu
injuri
delay
apoptosi
neutrophil
contribut
increas
cellular
damag
especi
lung
liver
kidney
gastrointestin
tract
acut
respiratori
distress
syndrom
ard
mark
signific
pulmonari
accumul
neutrophil
consid
direct
effect
neutrophilinduc
injuri
cell
retriev
lung
septic
patient
show
reduc
rate
neutrophil
apoptosi
degre
inhibit
parallel
sever
sepsi
addit
studi
shown
increas
apoptosi
via
fasfasldepend
mechan
pulmonari
epitheli
cell
lead
permeabl
chang
characterist
ard
cytokin
produc
activ
neutrophil
summon
macrophag
area
inflamm
cytokin
also
produc
tissu
macrophag
respons
foreign
invas
macrophag
antigenpres
cell
apc
capabl
engulf
foreign
materi
infect
cell
apoptot
cell
recognit
specif
cell
surfac
molecul
dendrit
cell
anoth
type
apc
view
sentinel
immun
system
like
macrophag
matur
dendrit
cell
abl
activ
lymphocyt
present
antigen
lymphocyt
need
signal
stimul
differenti
initi
immun
respons
first
signal
present
antigen
thu
account
specif
respons
second
signal
involv
costimulatori
molecul
apc
apc
secret
cytokin
costimulatori
molecul
interact
specif
cell
site
produc
proapoptot
antiapoptot
state
failur
appropri
second
signal
interact
apc
result
anergi
apoptosi
lymphocyt
anergi
state
unrespons
antigen
also
mechan
selftoler
immatur
dendrit
cell
capabl
ingest
apoptot
cell
render
incap
matur
stimul
cell
macrophag
dendrit
cell
secret
engulf
apoptot
cell
consid
antiinflammatori
cytokin
select
block
matur
dendrit
cell
shown
suppress
phagocyt
activ
well
proinflammatori
cytokin
product
alveolar
macrophag
also
secret
dendrit
cell
ingest
apoptot
cell
lead
autocrin
blockag
matur
lack
matur
lead
tolerogen
state
stimul
immun
system
ingest
apoptot
cell
dendrit
cell
matur
danger
signal
express
apoptot
cell
dendrit
cell
engulf
excess
number
apoptot
cell
lead
secret
proinflammatori
cytokin
tnfa
signal
dendrit
cell
inadequ
clearanc
surplu
apoptot
cell
result
cell
becom
necrot
induc
proinflammatori
respons
studi
demonstr
apoptosi
intestin
splenic
b
cell
cell
dendrit
cell
sepsi
overwhelm
infect
lead
massiv
clonal
expans
b
lymphocyt
instead
signific
loss
cell
line
sepsi
lack
stimul
apc
cell
experienc
apoptosi
lead
poor
b
cell
cell
stimul
unstimul
cell
remov
apoptosi
mani
bacterem
patient
die
system
inflammatori
respons
syndrom
multipl
organ
dysfunct
syndrom
focu
infect
identifi
prematur
b
cell
intestin
epitheli
cell
death
apoptosi
intestin
one
theori
explain
intestin
bacteri
transloc
loss
first
line
intestin
defens
treatment
strategi
current
human
treatment
strategi
manipul
apoptosi
focu
mainli
cancer
sepsi
pubm
literatur
search
time
write
reveal
total
citat
apoptosi
veterinari
studi
experiment
point
mani
oncolog
studi
manipul
apoptosi
treatment
patient
tabl
human
cancer
research
peptidomimet
earli
stage
experiment
studi
synthet
peptid
resist
enzymat
degrad
use
proapoptot
effect
bid
well
antagon
iap
cancer
treatment
trial
attempt
block
overexpress
cessat
normal
apoptosi
lead
growth
tumor
addit
direct
effect
apoptot
program
discoveri
made
allow
chemotherapeut
act
synergist
variou
antiapoptot
therapeut
treatment
strategi
sepsi
previous
target
hyperimmun
phase
rather
hypoimmun
phase
address
apoptosi
therapeut
challeng
target
blockad
apoptosi
lymphocyt
popul
must
specif
enough
primarili
target
cell
popul
undergo
increas
apoptosi
suffici
transient
prevent
risk
malign
transform
associ
prolong
blockad
apoptosi
pose
challeng
tri
target
specif
pathway
attempt
block
circul
mediat
cytokin
induc
apoptosi
success
inher
redund
failsaf
mechan
apoptot
pathway
caspas
inhibitor
show
promis
caspas
common
factor
mani
apoptot
pathway
broadspectrum
caspas
inhibitor
shown
prevent
lymphocyt
apoptosi
improv
surviv
anim
model
sepsi
caution
must
express
though
increas
dosag
caspas
inhibitor
caus
cytotox
tnfa
induc
injuri
gene
therapi
studi
shown
overexpress
delay
block
apoptosi
improv
surviv
septic
mice
therapi
target
akt
regul
cell
prolifer
death
mice
overexpress
akt
reduc
lymphocyt
apoptosi
increas
surviv
cecal
ligat
punctur
fa
fusion
protein
attempt
alter
gene
express
member
dr
pathway
also
area
ongo
apoptot
research
recombin
human
activ
protein
c
product
use
success
septic
patient
may
counteract
induct
apoptosi
monocyt
endotheli
cell
line
modul
inflammatori
coagul
cascad
sepsi
also
help
attenu
level
proand
antiapoptot
protein
favor
surviv
contrast
antiapoptot
strategi
recent
studi
address
hypothesi
apoptosi
sepsi
may
case
benefici
downregul
inflammatori
respons
earlier
onset
apoptosi
may
fact
favor
surviv
giarmarellosbourbouli
et
al
associ
monocyt
apoptosi
onset
sepsi
favor
outcom
due
decreas
amount
proinflammatori
cytokin
produc
apoptosi
normal
biolog
process
necessari
maintain
cellular
homeostasi
characterist
pathway
lead
form
cell
death
continu
influenc
local
cellular
event
growth
factor
neighbor
stress
complic
system
numer
builtin
avenu
failsaf
mechan
includ
proapoptot
antiapoptot
factor
sepsi
cancer
mani
diseas
caus
dysregul
apoptot
process
cell
either
kill
quickli
surviv
long
newer
therapi
design
manipul
apoptosi
depend
patholog
involv
promot
delay
form
cellular
demis
although
extrem
complic
process
understand
relationship
sepsi
apoptosi
undoubtedli
lead
new
treatment
modal
